Value Assessment and Health Outcomes Research Predoctoral Fellowship Grant

Value Assessment and Health Outcomes Research Predoctoral Fellowship Grant

Status: ACTIVE
Funder: Pharmaceutical Research And Manufacturers Of America Fnd Inc (PhRMA)
Amount: Up to US $60,000
Last Updated: August 15, 2025

Summary

The Value Assessment and Health Outcomes Research Predoctoral Fellowship, offered by the PhRMA Foundation, supports promising students in their advanced training and thesis research. This fellowship, aimed at U.S. and non-U.S. citizens, provides $30,000 in annual stipend support for up to two years. It encourages research proposals that address the effectiveness, safety, and value of healthcare interventions, emphasizing patient engagement and health equity in the evaluation process.

Overview

Mission The PhRMA Foundation is a 501(c)(3) nonprofit organization that fosters biopharmaceutical innovation and value-driven health care by investing in the frontiers of research. The Foundation catalyzes the careers of promising researchers through competitive, peer-reviewed grants and fellowships in the fields of drug delivery, drug discovery, translational medicine, and value assessment and health outcomes research. Vision A healthier world where all people have access to innovative, life-changing medicines. Values Integrity: We strive to be scientifically independent and evidence-based in our decision-making.Innovation: We invest in cutting-edge research and ideas that will improve patient health.Collaboration: We support collaborative research efforts that are diverse and inclusive. Value Assessment and Health Outcomes Research Predoctoral Fellowship The PhRMA Foundation’s Predoctoral Fellowship in Value Assessment-Health Outcomes Research (VA-HOR) is designed to support promising students (U.S. and non-U.S. citizens) during advanced stages of training and thesis research in value assessment and health outcomes research. Program Goals The PhRMA Foundation seeks research proposals that investigate challenges and potential solutions related to evaluating the delivery, safe use, effectiveness, and value (clinical, patient-centered, and economic) of medicines and other health care interventions. Proposals could be empirical analyses or studies addressing methodological aspects of the following areas: Clinical and economic outcomes using real-world data and analytic tools Clinical outcomes assessments Patient-reported and/or patient-centered outcomes, especially for diverse or underserved populations Patient health preferences research Evaluation and outcomes assessments focused on health equity or unmet need Innovative methods for measuring and reporting novel value elements (e.g., clinical, cost, health preference) from different stakeholder perspectives Development of innovative decision and communication tools Patient- and equity-centered value assessment frameworks Health policy research Proposals should incorporate patient engagement at an appropriate level to be responsive. Funding This award provides $30,000 in stipend support per year for 12, 18, or 24 months. Funding is conditional upon the awardee’s continued enrollment with the university, which will be assessed on a quarterly basis prior to payment. The awardee is required to notify the PhRMA Foundation if they leave the university or if they defend early. Payments will be made directly to the university on behalf of the awardee, with the understanding the university will administer the funds. This award is intended solely as a stipend; however, within the yearly award amount of $30,000, up to $1,000 (maximum) per year may be used for incidentals directly associated with thesis research preparation or travel to a scientific conference in the United States. An individual may not simultaneously hold another funding mechanism providing stipend support while the PhRMA Foundation predoctoral fellowship is active, unless it helps to supplement the award to a level that is consistent with other predoctoral fellowships the university offers. If necessary, the university may supplement the award to a level that is consistent with other predoctoral fellowships it currently offers.

Eligibility

You can learn more about this opportunity by visiting the funder's website. Applicants (U.S. and non-U.S. citizens) must attend an accredited U.S. university as full-time, in-residence students. Applicants will have completed most of their pre-thesis requirements (at least two years of coursework) and be engaged in thesis research as PhD candidates by the time the award is activated.Applicants should expect to complete their PhD requirements in two years or less from the time funding begins. The thesis adviser’s letter of support must verify the applicant’s doctoral candidacy.Fellows are expected to devote full time (including summers) to their research.Predoctoral fellowships should not be seen as a way to fund the principal investigator’s currently funded research project.

Ineligibility

Individuals just beginning graduate school should not apply.Applicants enrolled in MD/PhD programs should not be engaged in required clinical coursework or clerkships while the fellowship is active.The Foundation will not consider multiple applications for the same or similar efforts on the same project. If multiple applicants are submitting proposed efforts on the same project, the efforts must be separate activities and not duplicative. PhRMA Foundation funds may not be used for tuition, fringe benefits, or indirect costs to the university.Applicants who expect to complete their PhD requirements before April 1, 2026, should not apply.